Status:
COMPLETED
Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Acquired Immunodeficiency Syndrome
Eligibility:
All Genders
Brief Summary
The aim of the Post Marketing Study (PMS) is to evaluate the efficacy and safety profile of nevirapine in the management of the HIV/AIDS in an open environment.
Eligibility Criteria
Inclusion
- diagnosis of HIV/AIDS, no age limits
- patients could be naïve to treatment or pretreated with other antiretroviral agents
Exclusion
- Patients with known hypersensitivity to nevirapine or any other component of the product
Key Trial Info
Start Date :
June 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
442 Patients enrolled
Trial Details
Trial ID
NCT02191215
Start Date
June 1 2003
Last Update
July 16 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.